High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms

Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome

1995 • 994 citations

High-Mobility-Group Chromosomal Proteins: Architectural Components That Facilitate Chromatin Function

1996 • 752 citations

The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure.

1990 • 674 citations

The High Mobility Group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene

1992 • 632 citations

Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C

1995 • 608 citations

Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements

1993 • 440 citations

High level expression of the HMGI (Y) gene during embryonic development.

1996 • 306 citations

Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I(Y)

1995 • 280 citations

Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y).

1988 • 192 citations

Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter

1993 • 191 citations

Architectural Transcription Factors

1994 • 187 citations

The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias.

1995 • 183 citations

HMG-I/Y, a New c-Myc Target Gene and Potential Oncogene

2000 • 179 citations

cDNA cloning of the HML-C phosphoprotein, a nclear protein associated with neoplastic and undifferentiated phenotypes

1991 • 172 citations

Cooperativity between two NF-kappa B complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter.

1994 • 159 citations

SARs are cis DNA elements of chromosome dynamics: Synthesis of a SAR repressor protein

1995 • 156 citations

Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias

2000 • 154 citations

Multivalent DNA-binding properties of the HMG-1 proteins.

1996 • 152 citations

Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.

1998 • 143 citations

Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins.

1996 • 143 citations

Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization.

1993 • 134 citations

Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix.

1998 • 114 citations

Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis.

1991 • 113 citations

The Diagnostic Utility of the Keratin Profiles of Hepatocellular Carcinoma and Cholangiocarcinoma

1988 • 112 citations

Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins.

2000 • 99 citations

The significance of alpha‐fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours

1989 • 98 citations

Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker.

1999 • 95 citations

Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells.

1993 • 82 citations

High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases

2001 • 82 citations

Regional ‘pro-drug’ gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma

1998 • 74 citations

A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization

1996 • 63 citations

Histologic markers in primary and metastatic tumors of the liver

1988 • 62 citations

MOC31 Immunoreactivity in Primary and Metastatic Carcinoma of the Liver

2000 • 53 citations

Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion

2001 • 53 citations

Cooperativity between Two NF-κΒ Complexes, Mediated by High-Mobility-Group Protein I(Y), Is Essential for Cytokine-Induced Expression of the E-Selectin Promoter

1994 • 48 citations

Current treatment approaches in colorectal cancer.

1991 • 30 citations

Tissue Polypeptide Antigen—A Marker Antigen Differentiating Cholangioiar Tumors from Other Hepatic Tumors

1987 • 29 citations

Diagnostic Significance of High Mobility Group I(Y) Protein Expression in Intraductal Papillary Mucinous Tumors of the Pancreas

2002 • 29 citations

Blood-group-related antigen Lewis(x) and Lewis(y) in the differential diagnosis of cholangiocarcinoma and hepatocellular carcinoma.

1989 • 28 citations

Expression of theHMGI(Y) gene in human colorectal cancer

1999 • 27 citations

Telomerase Activity in Periampullary Tumors Correlates With Aggressive Malignancy

2001 • 26 citations